Majesty Therapeutics, .
Majesty Therapeutics, .
Stealth ModeDeveloping novel therapies for rare genetic disorders and unmet medical needs.
About
What does Majesty Therapeutics, . do?
Majesty Therapeutics is a biopharmaceutical company focused on the discovery and development of innovative therapeutic solutions for rare genetic diseases and other conditions with significant unmet medical needs. Their pipeline includes novel gene therapies and small molecule drugs aimed at improving patient outcomes.
What industry does Majesty Therapeutics, . operate in?
Majesty Therapeutics, . operates in Biotech, HealthTech, Drug Discovery, Genomics, Rare Diseases, Gene Therapy.
What is Majesty Therapeutics, .'s current status?
Majesty Therapeutics, .'s current operating status is: Inactive.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.